Neuronetics STIM Medical Device — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neuronetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuronetics's medical device — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuronetics's medical device — operating income?
- Neuronetics (STIM) reported medical device — operating income of $1.34M in Q1 2026.
- How has Neuronetics's medical device — operating income changed year-over-year?
- Neuronetics's medical device — operating income increased by 1087.5% year-over-year, from -$136K to $1.34M.
- What is the long-term trend for Neuronetics's medical device — operating income?
- Over 2 years (2022 to 2025), Neuronetics's medical device — operating income has grown at a -36.6% compound annual growth rate (CAGR), from -$35.11M to $14.12M.
- What does medical device — operating income mean?
- Operating income or loss represents the segment's profitability after deducting both the cost of goods sold and operating expenses from total revenue. It serves as a key measure of the segment's overall operational performance and its ability to generate sustainable earnings from core business activities.